Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.74% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.74% | 0.00% | |||
| Cost of Revenue | 4.18% | 5.11% | |||
| Gross Profit | -4.21% | -2.00% | |||
| SG&A Expenses | 0.67% | -3.46% | |||
| Depreciation & Amortization | -1.85% | -0.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.24% | 0.26% | |||
| Operating Income | -30.32% | -4.44% | |||
| Income Before Tax | -130.98% | -48.24% | |||
| Income Tax Expenses | -7,770.17% | -69.49% | |||
| Earnings from Continuing Operations | -92.14% | -45.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -92.14% | -45.48% | |||
| EBIT | -30.32% | -4.44% | |||
| EBITDA | -176.09% | -12.04% | |||
| EPS Basic | -90.61% | -44.43% | |||
| Normalized Basic EPS | -7.42% | -46.87% | |||
| EPS Diluted | -90.61% | -44.43% | |||
| Normalized Diluted EPS | -7.42% | -46.87% | |||
| Average Basic Shares Outstanding | 0.80% | 0.74% | |||
| Average Diluted Shares Outstanding | 0.80% | 0.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||